Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-21-019610
Filing Date
2021-05-17
Accepted
2021-05-17 16:10:15
Documents
2
Period of Report
2021-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1553
2 EX-24 DOCUMENT attachment1.htm EX-24 3249
  Complete submission text file 0000899243-21-019610.txt   6150
Mailing Address C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949
Business Address
Sharp Shalini (Reporting) CIK: 0001377202 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40235 | Film No.: 21930622

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 (908) 740-4000
Organon & Co. (Issuer) CIK: 0001821825 (see all company filings)

EIN.: 852269702 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations